We are monitoring the impact of COVID-19 on APAC Veterinary/Animal Vaccines Market Get in touch with us for detailed analysis Know More
Pulished Date February, 2020
ID: 64
Share on
Share on

Asia Pacific Veterinary/Animal Vaccines Market Analysis - By Type, Technology and Country (India, China, Japan, South Korea, Australia, New Zealand, Thailand, Malaysia, Vietnam, Philippines, Indonesia, Singapore and Rest of APAC) - Industry Analysis, Size, Share, Growth, Trends, Forecast | 2020 to 2025

Pulished: February, 2020
ID: 64
Pages: 135

APAC Veterinary/Animal Vaccines Market Size (2020 to 2025)

The Asia Pacific Veterinary/Animal Vaccines Market is poised to reach USD 1.53 Billion by 2025 from USD 1.08 Billion in 2020, at a CAGR of 7.22% from 2020 to 2025 and considered as the fastest-growing region in the global veterinary vaccines market.

Veterinary vaccines are mainly used to prevent transmission of diseases from animals to humans. These vaccines are specially manufactured to reduce or avoid contracting diseases. The main aim of veterinary vaccines is to promote good health and wellbeing of companion animals along with increasing production of poultry products with high quality.

Increasing prevalence for the production of quality products from the livestock population is a crucial driving factor for the market to grow. The rise in the incidences of various diseases like the zoonotic disease is accelerating the growth of the APAC veterinary vaccines market. People's concern towards animal health is growing eventually, which is solely to boost the demand of the market. Besides, on-going research to introduce innovative drugs is leveraging the growth of the market. 

However, the lack of skilled persons in developing various vaccines for different health disorders in animals is slowly hampering the growth of the market. Stringent rules and regulations by the government in approving new products are restraining the demand of the market. Also, increasing prices of treatment procedures in veterinary hospitals remains a challenging factor for the market growth in the Asia Pacific.  

Growth opportunities for the market lie in the increasing awareness over the availability of various treatment procedures for different diseases in animals through campaigns and digital advertisements. A growing number of veterinary hospitals and pharmaceutical industries are ascribed to outshine the growth rate of the market. Furthermore, the Veterinary vaccines market in the Asia Pacific is propelled by a rise in the demand to focus on immunization. Besides, shifting trend towards healthy lifestyles by maintaining a healthy diet with protein foods is likely to outshine the growth of the Veterinary/Animal vaccines market in the Asia Pacific. 

This research report segmented and sub-segmented into the following categories:

  • By Type: Livestock Vaccines and Companion Vaccines
  • By Technology: Live Attenuated Vaccines, Inactivated Vaccines, Recombinant Vaccines, Toxoid Vaccines, Subunit Vaccines, DNA Vaccines, and Conjugate Vaccines
  • By Country:  India, China, Japan, South Korea,  Australia, New Zealand, Thailand, Malaysia, Vietnam, Philippines, Indonesia, Singapore and Rest of APAC

Among all, the Indian Veterinary vaccines market is holding the highest shares of the market. Rising carious diseases in livestock are bolstering the demand of the market eventually. Also, growing awareness over the availability of different vaccines for various diseases is likely to magnify the need of the market.

The Veterinary/Animal vaccine market in China is also accounted to have significant shares of the market following India. Increasing revenue is one of the best parts for China to have leading shares in this market. A rise in the adoption of companion animals is boosting up the growth rate of the market.

Japanese Veterinary Vaccines Market is witnessed in having the fastest growth rate form the past few years and is also expected to have the same growth flow in the coming years. Shifting to DNA vaccines rather than live attenuated vaccines will increase the performance levels in controlling the diseases, and this is majorly considered as a growth factor for the market. Also, Adoption of recombinant vaccine solutions is fuelling the growth rate of the market in this country.

The market of veterinary vaccines in Australia is anticipated to have inclined growth rates in the coming years with rising awareness towards safety measurements for animal healthcare.

South Korean Veterinary Vaccine Market is deemed to have significant shares in the coming years by increasing investments from private and public organizations.

Prominent companies playing an active role in the Asia-Pacific Veterinary/Animal Vaccines Market are Bayer HealthCare AG, Bioniche Animal Health Canada, Sanofi Animal Health. Inc., Biogenesis Bago SA, Heska Corporation, Indian Immunologicals Ltd., Boehringer Ingelheim GmbH, Zoetis, Novartis Animal Health. Inc, Merck & Co. Inc and Protein Sciences.

  1. Introduction

                1.1 Market Definition                                                                    

                1.2 Study Deliverables                                                                  

                1.3 Base Currency, Base Year and Forecast Periods

                1.4 General Study Assumptions                                                                

  1. Research Methodology

                2.1 Introduction                                                                               

                2.2 Analysis Design                                                                         

                2.3 Research Phases                                                                      

                                2.3.1 Secondary Research                                                           

                                2.3.2 Primary Research                                                 

                                2.3.3 Econometric Modelling                                                      

                                2.3.4 Expert Validation                                                  

                2.4 Study Timeline                                                                          

  1. Overview

                3.1 Executive Summary                                                                

                3.2 Key Inferences                                                                         

                3.3 New Developments                                                               

  1. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)

                4.1 Market Drivers                                                                          

                4.2 Market Restraints                                                                    

                4.3 Key Challenges                                                                         

                4.4 Current Opportunities in the Market                                                                              

  1. Market Segmentation

                5.1 By Type                                                                        

                                5.1.1 Livestock vaccines                                                

                                                5.1.1.1 Bovine                                   

                                                5.1.1.2 Porcine                                 

                                                5.1.1.3 Ovine                                     

                                                5.1.1.4 Poultry                                  

                                                5.1.1.5 Equine                                   

                                5.1.2 Companion vaccines                                                           

                                                5.1.2.1 Canine                                   

                                                5.1.2.2 Feline                                    

                5.2 Technology                                                                 

                                5.2.1 Live attenuated vaccines                                                  

                                5.2.2 Inactivated vaccines                                                            

                                5.2.3 Recombinant vaccines                                                       

                                5.2.4 Toxoid vaccines                                                     

                                5.2.5 Subunit vaccines                                                   

                                5.2.6 DNA vaccines                                                         

                                5.2.7 Conjugate vaccines                                                             

  1. Geographical Analysis

                6.1 Introduction                                                                               

                6.2 China                                                                             

                6.3 India                                                                              

                6.4 Japan                                                                            

                6.5 South Korea                                                                               

  1. Strategic Analysis

                7.1 PESTLE analysis                                                                         

                                7.1.1 Political                                                     

                                7.1.2 Economic                                                 

                                7.1.3 Social                                                         

                                7.1.4 Technological                                                         

                                7.1.5 Legal                                                          

                                7.1.6 Environmental                                                       

                7.2 Porter’s Five analysis                                                                              

                                7.2.1 Bargaining Power of Suppliers                                                        

                                7.2.2 Bargaining Power of Consumers                                                    

                                7.2.3 Threat of New Entrants                                                     

                                7.2.4 Threat of Substitute Products and Services                                                              

                                7.2.5 Competitive Rivalry within the Industry                                                     

  1. Market Leaders' Analysis

                8.1 Bayer Healthcare AG                                                                              

                                8.1.1 Overview                                                 

                                8.1.2 Product Analysis                                                   

                                8.1.3 Strategic Evaluation and Operations                                                            

                                8.1.4 Financial analysis                                                  

                                8.1.5 Legal issues                                                             

                                8.1.6 Recent Developments                                                       

                                8.1.7 SWOT analysis                                                       

                                8.1.8 Analyst View                                                          

                8.2 Bioniche Animal Health Canada                                                                         

                8.3 Sanofi Animal Health Inc.                                                                      

                8.4 Biogenesis Bago SA                                                                 

                8.5 Heska Corporation                                                                  

                8.6 Indian Immunologicals Ltd.                                                                  

                8.7 Boehringer Ingelheim GmbH                                                                              

                8.8 Novartis Animal Health, Inc.                                                                

                8.9 Merck & Co. Inc.                                                                       

                8.10 Protein Sciences                                                                    

  1. Competitive Landscape

                9.1 Market share analysis                                                                            

                9.2 Merger and Acquisition Analysis                                                                       

                9.3 Agreements, collaborations and Joint Ventures                                                                         

                9.4 New Product Launches                                                                         

  1. Expert Opinions

                10.1 Market Outlook                                                                     

                10.2 Investment Opportunities                                                                 

     Appendix                                                                                          

  1. List of Tables
  2. List of Figures
  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. Asia-Pacific Veterinary Vaccines Market By Region, From 2020 to 2025 (USD Million)
  2. Asia-Pacific Veterinary Vaccines Market By Type, From 2020 to 2025 (USD Million)
  3. Asia-Pacific Livestock vaccines Market By Region, From 2020 to 2025 (USD Million)
  4. Asia-Pacific Companion vaccines Market By Region, From 2020 to 2025 (USD Million)
  5. Asia-Pacific Veterinary Vaccines Market By Technology, From 2020 to 2025 (USD Million)
  6. Asia-Pacific Live attenuated vaccines Market By Region, From 2020 to 2025 (USD Million)
  7. Asia-Pacific Inactivated vaccines Market By Region, From 2020 to 2025 (USD Million)
  8. Asia-Pacific Recombinant vaccines Market By Region, From 2020 to 2025 (USD Million)
  9. Asia-Pacific Toxoid vaccines Market By Region, From 2020 to 2025 (USD Million)
  10. Asia-Pacific Subunit vaccines Market By Region, From 2020 to 2025 (USD Million)
  11. Asia-Pacific DNA vaccines Market By Region, From 2020 to 2025 (USD Million)
  12. Asia-Pacific Conjugate vaccines Market By Region, From 2020 to 2025 (USD Million)
  13. Asia-Pacific Livestock Vaccines Market By Type, From 2020 to 2025 (USD Million)
  14. Asia-Pacific Bovine Market By Region, From 2020 to 2025 (USD Million)
  15. Asia-Pacific porcine Market By Region, From 2020 to 2025 (USD Million)
  16. Asia-Pacific Ovine Market By Region, From 2020 to 2025 (USD Million)
  17. Asia-Pacific Poultry Market By Region, From 2020 to 2025 (USD Million)
  18. Asia-Pacific Equine Market By Region, From 2020 to 2025 (USD Million)
  19. Asia-Pacific Companion Animal Vaccines Market By Type, From 2020 to 2025 (USD Million)
  20. Asia-Pacific canine Market By Region, From 2020 to 2025 (USD Million)
  21. Asia-Pacific feline Market By Region, From 2020 to 2025 (USD Million)
  22. China Veterinary Vaccines Market By Type, From 2020 to 2025 (USD Million)
  23. China Veterinary Vaccines Market By Technology, From 2020 to 2025 (USD Million)
  24. India Veterinary Vaccines Market By Type, From 2020 to 2025 (USD Million)
  25. India Veterinary Vaccines Market By Technology, From 2020 to 2025 (USD Million)
  26. Japan Veterinary Vaccines Market By Type, From 2020 to 2025 (USD Million)
  27. Japan Veterinary Vaccines Market By Technology, From 2020 to 2025 (USD Million)
  28. South Korea Veterinary Vaccines Market By Type, From 2020 to 2025 (USD Million)
  29. South Korea Veterinary Vaccines Market By Technology, From 2020 to 2025 (USD Million)
  30. China Livestock Vaccines Market By Type, From 2020 to 2025 (USD Million)
  31. India Livestock Vaccines Market By Type, From 2020 to 2025 (USD Million)
  32. Japan Livestock Vaccines Market By Type, From 2020 to 2025 (USD Million)
  33. South Korea Livestock Vaccines Market By Type, From 2020 to 2025 (USD Million)
  34. China Companion Animal Vaccines Market By Type, From 2020 to 2025 (USD Million)
  35. India Companion Animal Vaccines Market By Type, From 2020 to 2025 (USD Million)
  36. Japan Companion Animal Vaccines Market By Type, From 2020 to 2025 (USD Million)
  37. South Korea Companion Animal Vaccines Market By Type, From 2020 to 2025 (USD Million)

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 3335

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample